CompletedPhase 3NCT01232920

First-line Antimetabolites as Steroid-sparing Treatment Uveitis Pilot Trial

Studying Uveitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of California, San Francisco
Principal Investigator
S R Rathinam, MD
Aravind Eye Hospital
Intervention
Methotrexate(drug)
Enrollment
80 target
Eligibility
16 years · All sexes
Timeline
2010 – 2012

Study locations (2)

Collaborators

Aravind Eye Hospitals, India

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01232920 on ClinicalTrials.gov

Other trials for Uveitis

Additional recruiting or active studies for the same condition.

See all trials for Uveitis →

← Back to all trials